Stifel Initiates Coverage On Abeona Therapeutics with Buy Rating, Announces Price Target of $21

Benzinga · 05/30 12:05
Stifel analyst Dae Gon Ha initiates coverage on Abeona Therapeutics (NASDAQ:ABEO) with a Buy rating and announces Price Target of $21.